•
Sep 30, 2011

ResMed Q1 2012 Earnings Report

Total Revenue
$315M
Previous year: $282M
+11.6%
EPS
$0.33
Previous year: $0.37
-10.8%
Gross Profit
$185M
Previous year: $174M
+6.4%
Cash and Equivalents
$610M
Previous year: $540M
+13.0%
Free Cash Flow
$76.6M
Previous year: $43.8M
+74.9%
Total Assets
$1.94B
Previous year: $1.79B
+8.0%

ResMed

ResMed